Tirzepatide, another diabetes drug cleared for weight loss in US, yet to get regulator nod in India
New Delhi On 8 November, the US Food and Drug Administration (FDA) approved the use of tirzepatide by US pharma company Eli Lilly exclusively for obesity management. The injectable tirzepatide …